-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HST-1011 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HST-1011 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HST-1011 in Ovarian Cancer Drug Details: HST-1011 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HST-1011 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HST-1011 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HST-1011 in Solid Tumor Drug Details: HST-1011 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HST-1011 in Anal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HST-1011 in Anal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HST-1011 in Anal Cancer Drug Details: HST-1011 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HST-1011 in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HST-1011 in Rectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HST-1011 in Rectal Cancer Drug Details: HST-1011 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HST-1011 in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HST-1011 in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HST-1011 in Castration-Resistant Prostate Cancer (CRPC) Drug Details: HST-1011...
-
Government & Regulation
NewCanada Mining Fiscal Landscape – Regulations Governance and Sustainability
GlobalData's " Canada's Mining Fiscal Landscape Regulations Governance and Sustainability (2024)" provides a comprehensive coverage on Canada's mining fiscal regime. The report provides country's overview with macroeconomic performance, corruption index, Mineral sector capital expenditure and mineral overview. It also provides a comprehensive coverage on the country’s mining regulatory bodies, laws, mining leases and licenses, as well as taxes and royalties. The report further provides Canada's sustainable mining practices covering its climate targets Canada is one of the largest mineral producers...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VT-1021 in Gliosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VT-1021 in Gliosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VT-1021 in Gliosarcoma Drug Details: VT-1021 is under development for the treatment...